五洲医疗
(301234)
| 流通市值：5.15亿 | | | 总市值：19.01亿 |
| 流通股本：1841.21万 | | | 总股本：6800.00万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 342,595,211.54 | 212,130,611.53 | 90,040,221.08 | 533,679,925.02 |
| 营业收入 | 342,595,211.54 | 212,130,611.53 | 90,040,221.08 | 533,679,925.02 |
| 二、营业总成本 | 308,997,749.91 | 189,106,063.48 | 80,849,921.31 | 463,331,172.92 |
| 营业成本 | 283,091,808.79 | 175,449,986.11 | 75,271,891.42 | 419,950,006.1 |
| 税金及附加 | 2,454,713.65 | 1,543,032.57 | 893,867.26 | 2,669,847.09 |
| 销售费用 | 7,858,474.67 | 5,750,866.37 | 2,229,279.53 | 15,305,821.92 |
| 管理费用 | 12,286,929.05 | 7,392,456.68 | 3,266,177.73 | 19,946,827.57 |
| 研发费用 | 8,424,760.48 | 5,005,219.26 | 2,083,857.9 | 13,478,535.3 |
| 财务费用 | -5,118,936.73 | -6,035,497.51 | -2,895,152.53 | -8,019,865.06 |
| 其中:利息费用 | 7,460.94 | 3,808.67 | 1,391.24 | 12,244.19 |
| 其中:利息收入 | -3,336,257.67 | -2,691,040.41 | 1,711,770.77 | 5,097,268.36 |
| 加:公允价值变动收益 | 62,650.6 | -244,194.34 | -226,403.49 | -1,340,350.16 |
| 加:投资收益 | 1,740,896.22 | 1,082,642.12 | 311,723.18 | 3,624,942.91 |
| 资产处置收益 | 14,153.22 | 14,153.22 | 0 | - |
| 资产减值损失(新) | -2,158,056.28 | -2,006,385.72 | -1,153,004.67 | -2,731,496.49 |
| 信用减值损失(新) | -737,263.41 | -336,920.14 | 1,543,400.01 | -3,888,362.39 |
| 其他收益 | 8,354,861.38 | 4,686,648.28 | 2,291,047.37 | 2,461,791.25 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 40,874,703.36 | 26,220,491.47 | 11,957,062.17 | 68,475,277.22 |
| 加:营业外收入 | 4,153.82 | 50 | 50 | 3,413,366.08 |
| 减:营业外支出 | 661,134.21 | 485,777.71 | 12,274 | 950,370.57 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 40,217,722.97 | 25,734,763.76 | 11,944,838.17 | 70,938,272.73 |
| 减:所得税费用 | 5,882,393.61 | 3,967,293.4 | 2,060,162.57 | 10,673,217.29 |
| 六、净利润 | 34,335,329.36 | 21,767,470.36 | 9,884,675.6 | 60,265,055.44 |
| 持续经营净利润 | 34,335,329.36 | 21,767,470.36 | 9,884,675.6 | 60,265,055.44 |
| 归属于母公司股东的净利润 | 34,335,329.36 | 21,767,470.36 | 9,884,675.6 | 60,265,055.44 |
| (一)基本每股收益 | 0.5 | 0.32 | 0.15 | 0.89 |
| (二)稀释每股收益 | 0.5 | 0.32 | 0.15 | 0.89 |
| 九、综合收益总额 | 34,335,329.36 | 21,767,470.36 | 9,884,675.6 | 60,265,055.44 |
| 归属于母公司股东的综合收益总额 | 34,335,329.36 | 21,767,470.36 | 9,884,675.6 | 60,265,055.44 |
| 公告日期 | 2024-10-25 | 2024-08-24 | 2024-04-16 | 2024-04-16 |
| 审计意见(境内) | | | | 标准无保留意见 |